Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin Addition to Chemotherapy for Advanced Pancreatic Cancer
NCT06241352Phase 2Completed
- Sponsor
- Changhai Hospital
- Start
- Mar 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in pancreatic cancer (PC), sponsored by Changhai Hospital. Started Mar 2024; status: completed.
02
Drugs
atorvastatin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT06241352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06241352.